GLG News by Opana ER Prescribers (US)

The lack of a comprehensive EHR implementation suggests that we are failing at our goal of improving the healthcare system.  While the article highlights many problems, very few solutions are offered to remedy this part of our healthcare crises. The key implications are: 1....

There are well over 70 Million general anesthetics performed in the US each year, and the majority of these utilize one of four generally used inhaled anesthetic agents (Sevoflurane, Desflurane, Isoflurane and Halothane). How these drugs act to produce "unconsciousness" is largely unknown, but as the...

 Study will be ridiculed.   1) Comparator drug is not appropriate. 2) Not an outcomes study. 3) Time frame too short to be clinically significant. 4) Drug too expensive for first line use. 5) Long term safety not established.

1. The market for "depth of anesthesia" monitors has depended very much on marketing and public perception of the problem. This article shines a bright light on the more objective issues of utility and efficacy. 2. Aspect Medical has made a number of mis-steps over the years that have alienated them...

Prompt and effective pain control to decrease procedural pain is a significant benefit in the ER, ICU and OR department       

Missing in the article is the fact patients will still go to the physicians that they like regardless of the rating system.  This rating system of doctors is really economic credentialling.  Insurance companies will lower reimbursement unit values of physicians that are not rated...

Because the FDA warns about the misuse Of Fentora as a Cancer Pain Drug,  I hope that physicians will be very carefull about prescribing this very potent opiate medication.  Fortunately, the company Cephalon is correcting the problem without taking away the important role of this drug...

As a pharmaceutical consultant working in pain management area, I think lower dose will offer similar efficacy as Soma 350 mg but with a more favorable tolerability profile. Last week, Last week, The Food and Drug Administration (FDA) have approved 250 mg (lower dose) of Soma (carisoprodol) for treatment...

 Food and Drug Administration (FDA) has approved the first generic versions of Coreg (carvedilol).  It is good news for patients. Coreg is a widely used medication that is FDA-approved to treat high blood pressure, mild to severe chronic heart failure and left ventricular dysfunction following...

Under new Medicare regulations, hospitals will no longer receive higher payments for the additional costs associated with treating patients for certain hospital- acquired infections and medical errors. The new rules will give hospitals a powerful new incentive to improve patient care, according to Consumers...